Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.

Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, with a minimal header and the 403 message shown instead of the usual study details. This indicates the study information is currently inaccessible and the prior content is not visible in the page.SummaryDifference19%

- Check52 days agoChange DetectedThe funding disclosure now indicates NIH support for the study (2023). The protocol documentation has been updated to version v3.6.6, superseding the previous v3.6.5.SummaryDifference0.0%

- Check66 days agoChange DetectedThe Plain Language Summary section has been removed, taking away a lay-reader friendly overview of the study's purpose and design. This change affects how quickly a reader can understand the study at a glance.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page's revision tag moved from v3.6.4 to v3.6.5, signaling a maintenance update to the page rendering system. No study content or data appear to be changed.SummaryDifference0.0%

Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.